GC Pharma

Search
Keyword Search
Plasma Derivatives Office Vaccines Subsidiary Pipeline R&D Media Stock Company Recruit
Product Search
close
Total Menu KOR
close

ProductsProducts

GreenGene F inj.
GreenGene F inj.
GreenGene F inj.
GreenGene F inj.

Prescription Drugs

GreenGene F inj.

Effects
Bleeding symptom control and hemostasis for persons with hemophilia A
Description &
Ingredients
Blood coagulation factor VIII, recombinant & White or light yellow powder, odorless, colorless and transparent vials
Characteristics

Ingredients
1 vial (500 I.U. or 1000 I.U.) contains
Active Ingredients
-Beroctocog alfa (Antihemophilic factor VIII, recombinant)....................500 I.U. or 1000 I.U.
Inactive Ingredient
-Buffer: L-Histidine.......................................31.0mg
-Isotonizer: Sodium chloride.........................35.0mg
-Stabilizer: Polyethylene glycol 3350………..4.0mg
                   L-Arginine Hydrochloride………29.5mg
                   L-Glutamic Acid………………...33.6mg
                   L-Isoleucine……………………...3.7mg
                   Calcium Chloride 2 Hydrate……..2.4mg
                    Polysorbate 80……………………0.4mg
 
Effects
· GreenGene F is indicated in Hemophilia A (classical hemophilia) for the prevention and control of bleeding episodes and preoperative management. GreenGene F is not indicated for the treatment of von Willebrand’s disease.·
Usage/Dosage
· GreenGene F is administered by IV infusion after reconstitution of lyophilized powder with water for injection (4mL, provided).
After reconstitution, GreenGene F should be injected intravenously over several minutes.
Dosage should be consulted with physician.
Quantity per pack
· 500 IU
· 1,000 IU

 
Other
· Store at 2~8 ℃ in hermetic container. 
· Shelf life: 24 months from the date of manufacture
Precaution for use
· For administration precautions, please click the Download Manual button.
product detail


product detail


product detail

Last update 29 Mar 2017